These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8429832)

  • 21. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA; Cresswell P
    J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.
    Elliott EA; Drake JR; Amigorena S; Elsemore J; Webster P; Mellman I; Flavell RA
    J Exp Med; 1994 Feb; 179(2):681-94. PubMed ID: 8294875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processing to endoglycosidase H-resistant thyrotropin subunits occurs in the presence of brefeldin-A: evidence favoring the recycling of Golgi membranes to the rough endoplasmic reticulum in mouse thyrotrophs.
    Johnson MJ; Miura Y; Rubin D; Magner JA
    Thyroid; 1991; 1(2):185-94. PubMed ID: 1822366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
    Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
    J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A block in degradation of MHC class II-associated invariant chain correlates with a reduction in transport from endosome carrier vesicles to the prelysosome compartment.
    Zachgo S; Dobberstein B; Griffiths G
    J Cell Sci; 1992 Nov; 103 ( Pt 3)():811-22. PubMed ID: 1478973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74).
    Koch N; Moldenhauer G; Hofmann WJ; Möller P
    J Immunol; 1991 Oct; 147(8):2643-51. PubMed ID: 1918985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brefeldin A enables synthesis of active lipoprotein lipase in cld/cld and castanospermine-treated mouse brown adipocytes via translocation of Golgi components to endoplasmic reticulum.
    Park JW; Blanchette-Mackie EJ; Scow RO
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):125-34. PubMed ID: 8694753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.
    Jiang YZ; Couriel D; Mavroudis DA; Lewalle P; Malkovska V; Hensel NF; Dermime S; Molldrem J; Barrett AJ
    Immunology; 1996 Mar; 87(3):481-6. PubMed ID: 8778037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
    Agrawal B; Fraga E; Kane K; Singh B
    J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brefeldin A blocks the cytotoxicity of T cell receptor alpha/beta and gamma/delta cytotoxic T lymphocyte clones reacting against human autologous cancer cells.
    Wada Y; Ikeda H; Ueda D; Ohta M; Takahashi S; Hirata K; Sato N; Kikuchi K
    Jpn J Cancer Res; 1993 Aug; 84(8):906-13. PubMed ID: 8407555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells.
    Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H
    J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular transport of invariant chain-MHC class II complexes to the peptide-loading compartment.
    Xu X; Song W; Cho H; Qiu Y; Pierce SK
    J Immunol; 1995 Sep; 155(6):2984-92. PubMed ID: 7673716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.
    Peters PJ; Raposo G; Neefjes JJ; Oorschot V; Leijendekker RL; Geuze HJ; Ploegh HL
    J Exp Med; 1995 Aug; 182(2):325-34. PubMed ID: 7629497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum.
    Doms RW; Russ G; Yewdell JW
    J Cell Biol; 1989 Jul; 109(1):61-72. PubMed ID: 2745557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.